Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Safety and Complications of Laser, Radiofrequency, and Ultrasound Skin Tightening Devices

Description

The talk reviewed safety and complications of energy-based skin tightening devices, drawing on FDA MAUDE database reports and published studies. Radiofrequency devices, especially older monopolar systems, were linked to burns, blisters, fat loss, depressions, scarring, and pigment changes; these problems were attributed largely to improper technique or device issues. The speaker noted that safer radiofrequency practice uses lower energies with multiple passes, and emphasized that anesthesia can sometimes remove useful patient feedback about heat. Fractional radiofrequency microneedling has recently raised concern because reports include severe burns, disfigurement, fat loss, nerve damage, pain, erythema, and hyperpigmentation; correct needle insertion depth and energy settings are critical, especially in darker skin, where epidermal protection matters. Ultrasound-based tightening devices can also cause fat atrophy, nerve palsy, paresthesias, swelling, welts, blistering, ulceration, necrosis, and urticarial reactions if used too deeply, with poor coupling, excess gel, air pockets, or treatment over nerves. Newer ultrasound technologies appear safer by focusing energy more precisely in the dermis. Overall, the speaker concluded that these devices are effective and generally safe when used by well-trained operators with proper technique and patient selection.

View more

Conclusions

  • Ultrasound and radiofrequency-based tightening devices can be effective, but their safety depends heavily on proper technique, depth control, and operator training.
  • Many reported complications are associated with using excessive energy, treating too deeply, poor coupling, or incorrect device placement rather than the technologies themselves.
  • Monopolar radiofrequency appears safer when lower energies and multiple passes are used instead of a single high-energy pass, reducing risks such as fat atrophy.
  • Radiofrequency microneedling can cause burns, pigment changes, fat loss, and nerve injury, but many adverse events are preventable with correct needle insertion, depth selection, and skin-type-specific adjustments.
  • Fractional RF is generally well tolerated, with the most common adverse effects being pain, transient erythema, edema, and hyperpigmentation.
  • Microneedling devices that protect the epidermis, such as silicone-coated or properly engineered tips, are safer for darker skin types when used correctly.
  • Focused ultrasound can improve skin tightening without downtime, but it carries risks of nerve palsy, paresthesias, swelling, and in rare cases blistering, necrosis, or atrophy.
  • The greatest ultrasound risks occur when treatment is delivered over major nerves, with poor coupling, air pockets, excess gel, or incorrect focal depth.
  • Newer ultrasound systems with improved beam control and visualization may reduce the risk of epidermal injury, fat loss, and nerve damage.
  • Overall, tissue tightening technologies are considered safe and effective when used appropriately, but careful patient selection, education, and provider training are essential to minimize complications.
  • Tremaine AM, Avram MM. FDA MAUDE Data on Complications With Lasers, Light Sources, and Energy-Based Devices. Lasers in Surgery and Medicine. 2015;47:133-140. doi:10.1002/lsm.22328.#10.1002/lsm.22328
  • Chou M, Myers B, Avram M. Analysis of US Food and Drug Administration Data on Radiofrequency Microneedling Device Complications. Dermatologic Surgery.#10.1097/dss.0000000000005080
  • Friedmann DP, Bourgeois GP, Chan HHL, Zedlitz AC, Butterwick KJ. Complications From Microfocused Transcutaneous Ultrasound: Case Series and Review of the Literature. Lasers in Surgery and Medicine. 2018;50:13-19.#10.1002/lsm.22768
  • Fractional radiofrequency in the treatment of skin aging: an evidence-based treatment protocol.#10.1080/14764172.2019.1674448
  • Tremaine, Avram 2015.